FFCP PHASE1:Mm9::chr8:86264326..86264331,-: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{FFCP
|id=chr8:86264326..86264331,-
|short_description=p@chr8:86264326..86264331,-
|description=CAGE_peak_at_chr8:86264326..86264331,-
|association_with_transcript=NA
|E...") |
No edit summary |
||
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
| | |DHSsupport=NA | ||
| | |DPIdataset=NA | ||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |||
|cluster_id=chr8:86264326..86264331,- | |||
|description=CAGE_peak_at_chr8:86264326..86264331,- | |||
|id=chr8:86264326..86264331,- | |||
|ontology_enrichment_celltype=CL:0000988!1.16e-19!32;CL:0002032!1.16e-19!32;CL:0000037!1.16e-19!32;CL:0000566!1.16e-19!32;CL:0000837!1.16e-19!32;CL:0000838!1.87e-16!12;CL:0000791!2.84e-16!9;CL:0000789!2.84e-16!9;CL:0002420!2.84e-16!9;CL:0002419!2.84e-16!9;CL:0000790!2.84e-16!9;CL:0002031!2.83e-15!25;CL:0000542!3.97e-15!13;CL:0000051!3.97e-15!13;CL:0000084!3.17e-13!11;CL:0000827!3.17e-13!11;CL:0002320!5.47e-13!46;CL:0000134!5.47e-13!46;CL:0000624!5.58e-13!8;CL:0000738!2.24e-11!17;CL:0002087!2.24e-11!17;CL:0000219!1.00e-10!54;CL:0000034!2.15e-09!97;CL:0000723!7.07e-09!91;CL:0000048!7.07e-09!91;CL:0000063!2.33e-08!66;CL:0000049!3.05e-07!19;CL:0000144!6.30e-07!121;CL:0000012!6.30e-07!121;CL:0000553!7.45e-07!6;CL:0000556!7.45e-07!6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000815,4.85e-14,1;CL:0000792,4.85e-14,1;CL:0000945,6.50e-14,1;CL:0000236,6.50e-14,1;CL:0000826,6.50e-14,1;CL:0002031,8.12e-13,25;CL:0000838,3.61e-10,12;CL:0000988,4.41e-10,32;CL:0002032,4.41e-10,32;CL:0000037,4.41e-10,32;CL:0000837,4.41e-10,32;CL:0000542,1.94e-09,13;CL:0000051,1.94e-09,13;CL:0000553,3.47e-09,6;CL:0000556,3.47e-09,6;CL:0000738,2.28e-07,17;CL:0002087,2.28e-07,17;CL:0000624,2.84e-07,8;CL:0002320,4.36e-07,46;CL:0000134,4.36e-07,46 | |||
|ontology_enrichment_disease=DOID:0060100!5.62e-13!3;DOID:4045!5.62e-13!3 | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002384!5.47e-13!46 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002384,4.36e-07,46 | |||
|phase1_expression=0,0,0,0,0,0,0,2.84071311571468,0.140788722151667,0,0,0,0.856003649656029,0.786783621770977,0,0,0,1.26184866143295,1.09691546884591,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.418531630736908,0.7813353445238,1.0470474879476,7.05877785637217,0,0.485510353031154,0,0,0,0,0,0,0,0,0,2.68452169692378,1.45072428402269,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.240390899039938,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,2.84071311571468,0.140788722151667,0,0,0,0.856003649656029,0.786783621770977,0,0,0,1.26184866143295,1.09691546884591,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.418531630736908,0.7813353445238,1.0470474879476,7.05877785637217,0,0.485510353031154,0,0,0,0,0,0,0,0,0,2.68452169692378,1.45072428402269,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.240390899039938,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr8:86264326..86264331,- | |||
}} | }} |
Latest revision as of 05:02, 4 August 2015
Short description: | p@chr8:86264326..86264331, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr8:86264326..86264331, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
regulatory T cell | 4.85e-14 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 4.85e-14 | 1 |
lymphocyte of B lineage | 6.50e-14 | 1 |
B cell | 6.50e-14 | 1 |
pro-B cell | 6.50e-14 | 1 |
hematopoietic lineage restricted progenitor cell | 8.12e-13 | 25 |
lymphoid lineage restricted progenitor cell | 3.61e-10 | 12 |
hematopoietic cell | 4.41e-10 | 32 |
hematopoietic oligopotent progenitor cell | 4.41e-10 | 32 |
hematopoietic stem cell | 4.41e-10 | 32 |
hematopoietic multipotent progenitor cell | 4.41e-10 | 32 |
lymphocyte | 1.94e-09 | 13 |
common lymphoid progenitor | 1.94e-09 | 13 |
megakaryocyte progenitor cell | 3.47e-09 | 6 |
megakaryocyte | 3.47e-09 | 6 |
leukocyte | 2.28e-07 | 17 |
nongranular leukocyte | 2.28e-07 | 17 |
CD4-positive, alpha-beta T cell | 2.84e-07 | 8 |
connective tissue cell | 4.36e-07 | 46 |
mesenchymal cell | 4.36e-07 | 46 |
Ontology term | p-value | n |
---|---|---|
connective tissue | 4.36e-07 | 46 |